ArticleAmerican journal of cardiovascular drugs : drugs, devices, and other interventions2025

Disproportionality Analysis of Ivabradine in the US FDA Adverse Event Reporting System: A Real-World Study Across Overall and Indication-Specific Populations.

Jinghua Yang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.